Orthocell LtdASX: OCC

Orthocell Investor Webinar Details

Oct 19, 2026 at 5:57 PM EDT · Issued by Orthocell Ltd via ASX

Filed with ASX · Oct 19, 2026 at 5:57 PM EDT

On 6ix: 6ix.com/news/orthocell-investor-webinar-details

ASX Announcement Orthocell Webcast Details Quarter Ended 30 September 2026 Perth, Australia; 20 October 2026: Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) will announce its quarterly results for the period ended 30 September 2026 and host a webinar...

View Attachment

6ix hasn’t read this filing yet.

Orthocell Ltd on 6ix

In the deck

Orthocell — Q1 FY27 Earnings Presentation23 slidesOct 22, 2026

Earlier from Orthocell

Remplir Shows Excellent Early Prostatectomy ResultsOct 12
Letter to Shareholders, Notice of AGM & Proxy FormOct 2
Change of AuditorOct 1
Orthocell Achieves First Remplir Sales in ThailandSep 20
Cleansing NoticeSep 11

Later from Orthocell

Quarterly Activity Report & Appendix 4COct 21
Q1 FY27 OCC Investor PresentationOct 21
Strongest U.S. Remplir Sales Month Since LaunchNov 1
Marine Biomedical Achieves FDA ClearanceNov 2

All Orthocell news releases

Follow Orthocell into a list and get an email when it puts out news.

Follow Orthocell